structural parameters of the study programmes and to analyze study courses and use them as a basis for comparative and overarching analyses as well as an instrument for quality development. Funding body Lower Saxony
trialists for details of the studies. SELECTION CRITERIA: We included randomized controlled trials comparing growth factors (delivered directly or indirectly) with no intervention, placebo or any other in [...] (on approximately 1400 participants) with published results in the analyses. Six published studies compared fibroblast growth factors (FGF), four studies hepatocyte growth factors (HGF) and another four studies [...] register for Germany Instruments for risk prediction for cardiovascular diseases Drug-eluting stents compared to bypasssurgery for coronary heart disease Intravascular brachytherapy for peripheral arterial
women in 2022. Nevertheless, around 500 new MFA training contracts were signed in Germany in 2022, compared to the previous year. “We anticipate that the need for specialists in practices and other outpatient
immunotherapies are used for long-term treatment. In the study period, 2017 to 2019, these were comparatively inexpensive off-label therapies that had not yet been approved. They accounted for 13 percent
human leukocyte antigens (HLA), also play a role. These molecules on the surface of body cells are comparable to the blood group antigens on red blood cells and differ individually from person to person. In
hepatic encephalopathy, glucose turnover is reduced in the frontal and parieto-occipital cortex (B) compared to healthy individuals;(C) while at the same time it increases relatively in the basal ganglia and
better resemble the complexity of native tissue development, composition, morphology, and function compared to conventional cell culture approaches. The organoid technology can be used for a broad range of
Siebert, U. (2022). Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone–efficacy and safety, costs and cost-effectiveness, patients
acute kidney injury who were receiving intensive care for severe respiratory infections. These were compared with healthy control kidney tissue, which was obtained from non-diseased areas of the kidneys during
cells of the acquired immune system in the HCC tumor. To this end, samples of human tumor tissue are compared with healthy liver tissue and analyzed to determine which immune cells are active when and where